Christen A G, Christen J A
Department of Preventive and Community Dentistry, IUSD.
J Indiana Dent Assoc. 1992 Nov-Dec;71(6):12-8.
As Indiana dentists become involved in office-based smoking cessation efforts, they can prescribe the recently-developed Federal Drug Administration (FDA)-approved nicotine transdermal patch delivery systems for their smoking patients who wish to overcome nicotine addiction. This article reviews the evolutionary and scientific development of transdermal nicotine patch systems within an oral health setting. It discusses dental office-based cessation programs which have been designed by faculty members at the Indiana University School of Dentistry and by dentists who work with the National Cancer Institute. Finally, it presents the rationale for patch usage and specific techniques which are utilized in prescribing and monitoring this medication.
随着印第安纳州的牙医参与到基于诊所的戒烟工作中，他们可以为希望克服尼古丁成瘾的吸烟患者开具最近由美国食品药品监督管理局（FDA）批准的尼古丁透皮贴剂给药系统。本文回顾了口腔健康环境下尼古丁透皮贴剂系统的演变和科学发展。它讨论了由印第安纳大学牙科学院的教员以及与美国国家癌症研究所合作的牙医设计的基于牙科诊所的戒烟项目。最后，它阐述了使用贴剂的基本原理以及在开具和监测这种药物时所采用的具体技术。
